Mersana Therapeutics, Inc. - 59045L106

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 20
Latest filed: May 15, 2026
Form Count
4 13
SCHEDULE 13G/A 5
SCHEDULE 13D/A 1
8-K 1

Latest files

Filed Form Report period Accession SEC
May 15, 2026 SCHEDULE 13G/A 0001404574-26-000016 View
Feb 17, 2026 SCHEDULE 13G/A 0001404574-26-000005 View
Feb 17, 2026 SCHEDULE 13G/A 0001193805-26-000140 View
Jan 30, 2026 SCHEDULE 13G/A 0000102909-26-000157 View
Jan 09, 2026 SCHEDULE 13G/A 0001916761-26-000002 View
Jan 08, 2026 SCHEDULE 13D/A 0001193125-26-007752 View
Jan 06, 2026 8-K Jan 05, 2026 0001104659-26-001125 View
Jan 06, 2026 4 Jan 06, 2026 0001104659-26-001365 View
Jan 06, 2026 4 Jan 06, 2026 0001104659-26-001368 View
Jan 06, 2026 4 Jan 06, 2026 0001104659-26-001371 View
Jan 06, 2026 4 Jan 06, 2026 0001104659-26-001374 View
Jan 06, 2026 4 Jan 06, 2026 0001104659-26-001375 View
Jan 06, 2026 4 Jan 06, 2026 0001104659-26-001376 View
Jan 06, 2026 4 Jan 06, 2026 0001104659-26-001377 View
Jan 06, 2026 4 Jan 06, 2026 0001104659-26-001379 View
Jan 06, 2026 4 Jan 06, 2026 0001104659-26-001380 View
Jan 06, 2026 4 Jan 06, 2026 0001104659-26-001382 View
Jan 06, 2026 4 Jan 06, 2026 0001104659-26-001385 View
Jan 06, 2026 4 Jan 06, 2026 0001104659-26-001389 View
Jan 06, 2026 4 Jan 06, 2026 0001193125-26-004925 View